Cover Image

Virus-like Particle Vaccine Expressing the Respiratory Syncytial Virus Pre-Fusion and G Proteins Confers Protection against RSV Challenge Infection

Respiratory syncytial virus (RSV) causes severe lower respiratory tract disease in children and the elderly. However, there are no effective antiviral drugs or licensed vaccines available for RSV infection. Here, RSV virus-like particle (VLP) vaccines expressing Pre-F, G, or Pre-F and G proteins on...

Full description

Saved in:

Bibliographic Details
Main Authors:	Su-Hwa Lee (Author), Ki-Back Chu (Author), Min-Ju Kim (Author), Jie Mao (Author), Gi-Deok Eom (Author), Keon-Woong Yoon (Author), Md Atique Ahmed (Author), Fu-Shi Quan (Author)
Format:	Book
Published:	MDPI AG, 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
by: Andrea Gastaldi, et al.
Published: (2021)

Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants
by: Lu Wang, et al.
Published: (2021)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
by: Xiao Li, et al.
Published: (2024)

The new reporting obligation for Respiratory Syncytial Virus (RSV) in Germany - a critical view
by: Heudorf, Ursel, et al.
Published: (2024)

Respiratory syncytial virus (RSV) disease - new data needed to guide future policy
by: Louis Bont, et al.
Published: (2015)

Current Insights Into Host Immune Responses to Human Respiratory Syncytial Virus (RSV) and Challenges Towards Efficient Treatments and Vaccines Against RSV
Published: (2020)

Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy
by: Domenico Ponticelli, et al.
Published: (2024)

Serological Survey Of Respiratory Syncytial Virus (RSV) Among Children In Lorin North-Central, Nigeria.
by: Odebisi- Omokanye, et al.
Published: (2018)

Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats
by: Hye Suk Hwang, et al.
Published: (2017)

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey
by: Qiang Wang, et al.
Published: (2024)

The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya
by: Joyce U. Nyiro, et al.
Published: (2024)

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
by: Nienke M Scheltema, MD, et al.
Published: (2017)

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children
by: Simões Eric AF, et al.
Published: (2011)

FACTORS DETERMINING THE HOSPITALISATION DURATION OF STAY IN CHILDREN WITH SEVERE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN THE RUSSIAN FEDERATION
by: A.A. Baranov, et al.
Published: (2011)

FACTORS DETERMINING THE HOSPITALISATION DURATION OF STAY IN CHILDREN WITH SEVERE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN THE RUSSIAN FEDERATION
by: A.A. Baranov, et al.
Published: (2011)

Discovery of N-Containing (-)-Borneol Esters as Respiratory Syncytial Virus Fusion Inhibitors
by: Anastasiya S. Sokolova, et al.
Published: (2022)

Adjustable Algorithmic Tool for Assessing the Effectiveness of Maternal Respiratory Syncytial Virus (RSV) Vaccination on Infant Mortality in Developing Countries
by: Rachel Cevigney, et al.
Published: (2021)

Respiratory syncytial virus infection and the need for immunization in Korea
by: Hye Young Kim, et al.
Published: (2023)

The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference
by: Paul Engeroff, et al.
Published: (2019)

Identifying climatic drivers of respiratory syncytial virus (RSV) seasonality in Antananarivo, Madagascar, 2011-2021: a sentinel surveillance study
by: Jean-Michel Heraud, et al.
Published: (2024)

Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey
by: Jo Won Jung
Published: (2011)

Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles
by: Youri Lee, et al.
Published: (2017)

The Cumulative Variations of Respiratory Syncytial Virus Fusion Protein (F) in Ten Consecutive Years in China
by: Fengjie Wang, et al.
Published: (2024)

Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trials
by: Sandy Lewis, et al.
Published: (2018)

Evolving Epidemiology of Pediatric Respiratory Syncytial Virus (RSV) Cases Around COVID-19 Pandemic: Impact and Clinical Insights, Retrospective Cohort Study
by: Deema Gashgarey, et al.
Published: (2024)

Implications of gestational age at antenatal care attendance on the successful implementation of a maternal respiratory syncytial virus (RSV) vaccine program in coastal Kenya
by: Joyce U. Nyiro, et al.
Published: (2020)

A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States
by: Martine C. Maculaitis, et al.
Published: (2024)

Evaluation of CpG-ODN-Adjuvanted <i>Toxoplasma gondii</i> Virus-Like Particle Vaccine upon One, Two, and Three Immunizations
by: Hae-Ji Kang, et al.
Published: (2020)

Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies
by: Francesca Centrone, et al.
Published: (2024)

A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season
by: Griffin M Pamela, et al.
Published: (2010)

Respiratory syncytial virus-related hospitalization in premature infants without bronchopulmonary dysplasia: subgroup efficacy analysis of the IMpact-RSV trial by gestational age group
by: Notario G, et al.
Published: (2014)

Identification of miRNA-mRNA Crosstalk in Respiratory Syncytial Virus- (RSV-) Associated Pediatric Pneumonia through Integrated miRNAome and Transcriptome Analysis
by: Xu Zhang, et al.
Published: (2020)

Active immunoprophylaxis with a synthetic DNA-encoded monoclonal anti-respiratory syncytial virus scFv-Fc fusion protein confers protection against infection and durable activity
by: Katherine Schultheis, et al.
Published: (2020)

Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B
by: M. Gordon Joyce, et al.
Published: (2019)

Chapter 5 Respiratory Syncytial Virus
by: Jha, Akhilesh
Published: (2016)

Chapter 5 Respiratory Syncytial Virus
by: Jha, Akhilesh
Published: (2016)

Human Respiratory Syncytial Virus Infection
Published: (2011)

Neonatal priming and infancy boosting with a novel respiratory syncytial virus vaccine induces protective immune responses without concomitant respiratory disease upon RSV challenge
by: Shuren Zhang, et al.
Published: (2020)

Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants
by: Ravasio Roberto, et al.
Published: (2009)

Machine learning early prediction of respiratory syncytial virus in pediatric hospitalized patients
by: Chak Foon Tso, et al.
Published: (2022)